By conducting these studies, we are moving toward a common goal: to elucidate the mechanisms of the effects of the Nrf2/HO-1 pathway on IBD and the complex role of potential drugs targeting Nrf2/HO-1 in the prevention of IBD and its chronic complications. This evidence concerns the gene HMOX1 and inflammatory bowel disease.